Ceric ammonium nitrate 分子结构式
HCID180504

Ceric ammonium nitrate

diazanium;cerium(4+);hexanitrate

CeH8N8O18548.22 g/molCAS 10139-51-2

IDENTITY

结构与身份

标准SMILES
O=[N+]([O-])[O-].O=[N+]([O-])[O-].O=[N+]([O-])[O-].O=[N+]([O-])[O-].O=[N+]([O-])[O-].O=[N+]([O-])[O-].[Ce+4].[NH4+].[NH4+]
InChIKey
XMPZTFVPEKAKFH-UHFFFAOYSA-P
分子式
CeH8N8O18
平均分子量
548.22 g/mol
单同位素质量
547.9011

COMPUTED

结构计算性质

已同步
极性表面积
379 Ų
氢键供体
2
氢键受体
18
可旋转键
0
重原子
27
形式电荷
0
复杂度
18

PROPERTIES

实验与物化性质

来源:PubChem
Physical Description

Orange solid, soluble in water; [Merck Index]

GHS

GHS分类

来源:PubChem
GHS Classification

Danger

H272 (99.4%): May intensify fire; oxidizer [Danger Oxidizing liquids; Oxidizing solids];H302 (92.6%): Harmful if swallowed [Warning Acute toxicity, oral];H314 (67.4%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation];H315 (28%): Causes skin irritation [Warning Skin corrosion/irritation];H317 (66.3%): May cause an allergic skin reaction [Warning Sensitization, Skin];H318 (68%): Causes serious eye damage [Danger Serious eye damage/eye irritation];H319 (29.1%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H335 (26.9%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation];H400 (65.1%): Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard];H410 (65.7%): Very toxic to aquatic life with long lasting effects [Warning Hazardous to the aquatic environment, long-term hazard]

P210, P220, P260, P261, P264, P264+P265, P270, P271, P272, P273, P280, P301+P317, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P351+P338, P305+P354+P338, P316, P317, P319, P321, P330, P332+P317, P333+P317, P337+P317, P362+P364, P363, P370+P378, P391, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 175 reports by companies from 19 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

HAZARDS

危害信息

来源:PubChem
Regulatory Information

Status: Active Update: 24-03-2022 https://echa.europa.eu/registration-dossier/-/registered-dossier/11355

Hazards Summary

See Cerium. See RARE EARTH METALS and linked occupational diseases.

Hazard Classes and Categories

Ox. Sol. 2 (99.4%);Acute Tox. 4 (92.6%);Skin Corr. 1B (67.4%);Skin Irrit. 2 (28%);Skin Sens. 1A (66.3%);Eye Dam. 1 (68%);Eye Irrit. 2 (29.1%);STOT SE 3 (26.9%);Aquatic Acute 1 (65.1%);Aquatic Chronic 1 (65.7%)

SAFETY

安全与防护

来源:PubChem
Protective Action Criteria (PAC)

0.054 [mg/m3]

0.58 [mg/m3]

3.5 [mg/m3]

TOXICITY

毒理信息

来源:PubChem
Treatment

Methemoglobinemia can be treated with supplemental oxygen and methylene blue 1% solution administered intravenously slowly over five minutes followed by IV flush with normal saline. Methylene blue restores the iron in hemoglobin to its normal (reduced) oxygen-carrying state. (L1613)

Health Effects

Nitrate and nitrite poisoning causes methemoglobinemia. Nitrites may cause pregnancy complications and developmental effects. They may also be carcinogenic. (L1137)

Adverse Effects

Fibrogenic - Inducing tissue injury and fibrosis (scarring).

Exposure Routes

Oral (L1137) ; inhalation (L1137)

Toxicity Summary

Nitrate's toxicity is a result of it's conversion to nitrite once in the body. Nitrite causes the autocatalytic oxidation of oxyhemoglobin to hydrogen peroxide and methemoglobin. This elevation of methemoglobin levels is a condition known as methemoglobinemia, and is characterized by tissue hypoxia, as methemoglobin cannot bind oxygen. (A2450, L1613)

Signs and Symptoms

Nitrate and nitrite poisoning causes methemoglobinemia. Symptoms include cyanosis, cardiac dysrhythmias and circulatory failure, and progressive central nervous system (CNS) effects. CNS effects can range from mild dizziness and lethargy to coma and convulsions. (L1137)

Carcinogen Classification

Ingested nitrate or nitrite under conditions that result in endogenous nitrosation is probably carcinogenic to humans (Group 2A). (L135)

REGULATORY

法规信息

来源:PubChem
Regulatory Information

Status: Active Update: 24-03-2022 https://echa.europa.eu/registration-dossier/-/registered-dossier/11355

PHARMACOLOGY

药理信息

来源:PubChem
Metabolism/Metabolites

Intake of some amount of nitrates and nitrites is a normal part of the nitrogen cycle in humans. In vivo conversion of nitrates to nitrites can occur in the gastrointestional tract under the right conditions, significantly enhancing nitrates' toxic potency. The major metabolic pathway for nitrate is conversion to nitrite, and then to ammonia. Nitrites, nitrates, and their metabolites are excreted in the urine. (L1137)

USES

用途与制造

来源:PubChem
Uses

Used as a standard in oxidimetry and an oxidant in redox reactions; Used in a solution of perchloric acid to etch printed circuits; [Merck Index]

General Manufacturing Information

Cerate(2-), hexakis(nitrato-.kappa.O)-, ammonium (1:2), (OC-6-11)-: ACTIVE

ALIASES

名称与别名

共 24 条
Cerium ammonium nitrateDiammonium hexanitratocerate10139-51-2U99S55ED6BNSC-215187RefChem:124502lambda4-cerium(4+) ion bis(nitric acid) diamine tetranitrate240-827-6Ammonium cerium nitrateAmmonium hexanitratocerateAmmonium hexanitratocerate(IV)Cerate(2-), hexakis(nitrato-kappaO)-, ammonium (1:2), (OC-6-11)-Ceric ammonium nitrateCeric(IV) ammonium nitrateAmmonium cerium IV Nitratediazanium;cerium(4+);hexanitrateSCHEMBL313904cerium (IV) diammonium nitratediammonium cerium (IV) nitratedi-ammonium cerium (IV) nitrate

REACTIONS

参与反应

301
HRID 31915 反应方程式

uspto-grants-2008_09 · 10.6084/m9.figshare.5104873.v1 · US07425557B2

查看
HRID 38136 反应方程式

uspto-grants-2013_09 · 10.6084/m9.figshare.5104873.v1 · US08524721B2

查看
HRID 57082 反应方程式

uspto-grants-2016_09 · 10.6084/m9.figshare.5104873.v1 · US09434712B2

查看
HRID 57112 反应方程式

uspto-grants-2016_09 · 10.6084/m9.figshare.5104873.v1 · US09434712B2

查看
HRID 63806 反应方程式

uspto-grants-2016_09 · 10.6084/m9.figshare.5104873.v1 · US09447006B2

查看
HRID 63812 反应方程式

uspto-grants-2016_09 · 10.6084/m9.figshare.5104873.v1 · US09447006B2

查看
HRID 63814 反应方程式

uspto-grants-2016_09 · 10.6084/m9.figshare.5104873.v1 · US09447006B2

查看
HRID 63816 反应方程式

uspto-grants-2016_09 · 10.6084/m9.figshare.5104873.v1 · US09447006B2

查看